Tammie L.S. Benzinger

Author

Washington University in St. Louis ORCID

Also Known As

Alena Kreychman, Alison M. Goate, Anne M. Fagan, Aschenbrenner, Andrew J., Benzinger, T, Benzinger, Tammie L. S., Benzinger, Tammie L.S., Carol Hulle, Danielle M. Picarello, Fatima Amtashar

1.1K

Publications

42K

Citations

H-Index

200

Concepts

All Affiliations

Washington University in St. Louis Mallinckrodt (United States)Hope Center for Neurological Disorders Massachusetts General Hospital German Center for Neurodegenerative Diseases

About

Tammie L.S. Benzinger is an author at Washington University in St. Louis specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	95	11.7K
2	Health Sciences	20	29	2.5K
3	Engineering	12	13	1.5K
4	Natural Sciences	5	5	632
5	Public Health	1	1	39

Tammie L.S. Benzinger

339

Publications

37K

Citations

H-Index

Page 1

	Year	Citations
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger, New England Journal of Medicine	2012	3.7K
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction Daniel A. Nation, Melanie D. Sweeney, Axel Montagne, Nature Medicine Neuroimaging BiomarkersNeuropsychologyHuman Cognitive DysfunctionBlood–brain BarrierNeurophysiology	2019	1.6K
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET William E. Klunk, Robert A. Koeppe, Julie C. Price, Alzheimer s & Dementia	2014	1.2K
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline Axel Montagne, Daniel A. Nation, Abhay P. Sagare, Nature Neurodegenerative DiseasesMedicineBrain HealthNeurochemical BiomarkersNeurology	2020	1.2K
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis Suzanne E. Schindler, James G. Bollinger, Vitaliy Ovod, Neurology	2019	851
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Journal of Clinical Oncology	2020	783
OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease Pamela LaMontagne, Tammie L.S. Benzinger, John C. Morris, Geriatric PsychiatryAgingAbstract Oasis-3Longitudinal NeuroimagingGeriatric Neurology	2019	756
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease Matthew R. Brier, Brian A. Gordon, Karl A. Friedrichsen, Science Translational Medicine	2016	721
Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer's Disease Progression Matthew R. Brier, John B. Thomas, Abraham Z. Snyder, Journal of Neuroscience	2012	596
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study Brian A. Gordon, Tyler Blazey, Yi Su, The Lancet Neurology Neuroimaging BiomarkersAlzheimer's DiseaseDementiaFrontotemporal DementiaNeurochemical Biomarkers	2018	588

Page 1